首页> 外文OA文献 >Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: A pilot study

【2h】

Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: A pilot study

机译：通过动脉内化疗，组合依托泊苷，卡铂，同质素和药代动力学调节化疗的动脉化疗治疗的肝细胞癌与门静脉肿瘤血栓形成的生存期通过5-FU和Enteric-Coed Tegafur / Uracil：试验研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Toru Ishikawa;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil [J] . Toru Ishikawa, Michitaka Imai, Hiroteru Kamimura, World Journal of Gastroenterology . 2007,第41期

机译：通过动脉内化疗联合依托泊苷，卡铂，表柔比星和5-FU肠溶替加氟/尿嘧啶的药代动力学调节化疗治疗肝细胞癌并合并门静脉肿瘤血栓的存活率
2. Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. [J] . Cheong JY, Lee KM, Cho SW, Hepatology research: the official journal of the Japan Society of Hepatology . 2005,第2期

机译：动脉内灌注化疗对晚期肝细胞癌合并门静脉瘤栓塞的患者的生存获益。
3. A Case of Advanced Multiple Hepatocellular Carcinomas with Portal Vein Tumor Thrombosis Successfully Treated by Oral Tegafur/Uracil [J] . Hiroto Tanaka, Huuta Koga, Masako Hasegawa, Journal of Cancer Therapy . 2010,第3期

机译：口服替加福/尿嘧啶成功治疗门静脉肿瘤血栓形成的晚期多发性肝癌一例
4. Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide carboplatin epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: A pilot study [O] . Toru Ishikawa, Michitaka Imai, Hiroteru Kamimura, 2007

机译：动脉内化疗结合依托泊苷卡铂表柔比星和5-FU肠溶替加氟/尿嘧啶的药代动力学调节化疗治疗肝细胞癌合并门静脉肿瘤血栓形成的生存率：一项先导研究
5. A Case of Advanced Multiple Hepatocellular Carcinomas with Portal Vein Tumor Thrombosis Successfully Treated by Oral Tegafur/Uracil [O] . Hiroto Tanaka, Huuta Koga, Masako Hasegawa, 2010

机译：口服替加氟/尿嘧啶成功治疗门静脉肿瘤血栓形成的晚期多发性肝癌一例

Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: A pilot study

著录项

引文网络

相似文献

相关主题

期刊订阅